HOME >> MEDICINE >> NEWS
ACTOS reduces stroke by almost 50 percent

Barcelona, Spain, September 3, 2006 -- Results of new analyses found that ACTOS (pioglitazone HCl), an oral antidiabetic medication, significantly reduced the risk of recurrent stroke in high-risk patients with type 2 diabetes. The findings were presented today in a late-breaker session at the World Congress of Cardiology in Barcelona.

"These results are very encouraging news for people with type 2 diabetes because they demonstrated that ACTOS reduced the incidence of strokes in patients who had already experienced a stroke from 10.2 percent down to 5.6 percent, translating to a risk reduction of almost 50 percent," said Robert Wilcox, M.D., professor in the Department of Cardiovascular Medicine at Queen's Medical Centre, University Hospital, Nottingham, United Kingdom.

These new analyses from the landmark PROactive Study examined the effects of ACTOS on the risk of stroke and other cardiovascular (CV) outcomes in high-risk patients with type 2 diabetes with and without prior stroke. Pre-specified study endpoints included all-stroke and CV disease death, myocardial infarction (MI, excluding silent MI) or stroke.

According to the results, there were statistically significant benefits of ACTOS in patients who had suffered a prior stroke. The incidence of recurrent stroke was reduced by 47 percent (P=0.008) and the combined risk of death, MI or stroke was reduced by 28 percent (P<0.05). There was no effect of ACTOS on subsequent strokes in patients who had never experienced a stroke.

Patients with diabetes are at an increased risk of stroke. In fact, the risk is two to four times higher for people with diabetes than the general population. Results from the PROactive Study demonstrated that an oral glucose-lowering medication could substantially impact the risk of some CV events, including the combined risk of death, MI and stroke in high-risk patients with type 2 diabetes.


'"/>

Contact: Amy Losak
amy.losak@ketchum.com
646-935-3917
Ketchum
5-Sep-2006


Page: 1

Related medicine news :

1. ACTOS (pioglitazone HCl) demonstrates significant improvements in cardiovascular outcomes
2. ACTOS (pioglitazone HCl) to be studied in new trial
3. New data shows ACTOS reduced heart attacks by 28 percent in people with type 2 diabetes
4. ACTOS (pioglitazone HCl) significantly improved components of diabetic dyslipidemia
5. Nonhormonal drug reduces hot flashes in men treated for prostate cancer
6. Circumcision reduces HIV infection risk
7. Retinol lotion reduces the fine wrinkles from natural aging of skin
8. Improving communication with families of dying patients reduces stress, anxiety and depression
9. New study: Pycnogenol reduces heart failure
10. Drinking farm milk reduces childhood asthma and allergies but raw consumption remains unsafe
11. Angioplasty reduces long-term cardiac risk among heart patients with silent ischemia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... , ... September 03, 2020 , ... ... Approval for Sunrise Technologies WALI wireless parking lot controller. This advanced LED wireless ... glare, reducing light trespass, and protecting the night sky against light pollution. Leo ...
(Date:9/1/2020)... ... 2020 , ... Feeding Matters , the first organization in the world ... is pleased to announce that the U.S. Centers for Disease Control and Prevention (CDC) ... next edition of the U.S. International Classification of Diseases (ICD ) on October ...
(Date:8/31/2020)... ... August 31, 2020 , ... The Lymphoma Research ... innovative lymphoma research and serving the lymphoma community through a comprehensive series of ... of Blood Cancer Awareness Month (BCAM) and its international Light it Red ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... for chiropractors, announced today the launch of its integrated, HIPAA compliant, telehealth solution, ... their virtual practice in under 90 seconds. , According to the U.S. ...
(Date:8/31/2020)... ... ... A Cure for Covid-19 “PTS” with Mediation & Hypnosis , At this very turbulent ... panic, experiencing deep anxiety, immense stress, and right now are needing serious relief from a ... on the planet are experiencing a great degree of emotional discomfort, be it fear or ...
Breaking Medicine News(10 mins):
(Date:8/27/2020)... Texas (PRWEB) , ... August 27, 2020 , ... Austin ... Texas – is pleased to announce Dr. David Szalay, DDS, MD, has joined the ... treat patients in the new Pflugerville office, which is scheduled to open this fall. ...
(Date:8/27/2020)... , ... August 27, 2020 , ... The GHT ... of its fundraising initiative for Feeding San Diego with a press conference ... GHT Companies presents the final check of $5,000.00+ representing an overall donation result exceeding ...
(Date:8/26/2020)... (PRWEB) , ... August 26, ... ... Holdings company today announced that it has entered into definitive agreement to ... CME/CE, primarily focused on pharmacists and pharmacy technicians. , CEA represents ...
Breaking Medicine Technology:
Cached News: